Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Aouizerate

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
The International Journal of Neuropsychopharmacology|February 17, 2022
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic MarkersRicard Navinés, Giovanni Oriolo, Igor Horrillo, et al.
Brain, Behavior, and Immunity|March 8, 2021
Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlatesLison Huet, Ines Delgado, Sandra Dexpert, et al.
Addiction Biology|June 9, 2006
Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppressionBruno Aouizerate, Ann Ho, James H Schluger, et al.
BMC Cardiovascular Disorders|April 19, 2015
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndromeMarianne Lafitte, Sandrine Tastet, Paul Perez, et al.
L'Encephale|February 18, 2024
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024Antoine Yrondi, Hervé Javelot, Bénédicte Nobile, et al.
Psychoneuroendocrinology|March 12, 2018
Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic healthInes Delgado, Lison Huet, Sandra Dexpert, et al.
Brain, Behavior, and Immunity|March 16, 2026
Inflammation-Related alterations in tyrosine metabolism are associated with anhedonia and reduced motivation in Obesity: Influence of Early-Life adversityJuliette Montet, Enrica Montalban, Sandra Dexpert, et al.
Journal of Affective Disorders|December 11, 2019
Evaluation of a virtual agent to train medical students conducting psychiatric interviews for diagnosing major depressive disordersLucile Dupuy, Jean-Arthur Micoulaud-Franchi, Hélène Cassoudesalle, et al.
International Journal of Obesity (2005)|January 10, 2022
Association between the indole pathway of tryptophan metabolism and subclinical depressive symptoms in obesity: a preliminary studyInês Delgado, Sofia Cussotto, Andrea Anesi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2009
Inverse relationship between thalamic and orbitofrontal volumes in obsessive-compulsive disorderJean-Yves Rotge, Bixente Dilharreguy, Bruno Aouizerate, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
The International Journal of Neuropsychopharmacology|February 17, 2022
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic MarkersRicard Navinés, Giovanni Oriolo, Igor Horrillo, et al.
Brain, Behavior, and Immunity|March 8, 2021
Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlatesLison Huet, Ines Delgado, Sandra Dexpert, et al.
Addiction Biology|June 9, 2006
Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppressionBruno Aouizerate, Ann Ho, James H Schluger, et al.
BMC Cardiovascular Disorders|April 19, 2015
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndromeMarianne Lafitte, Sandrine Tastet, Paul Perez, et al.
L'Encephale|February 18, 2024
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024Antoine Yrondi, Hervé Javelot, Bénédicte Nobile, et al.
Psychoneuroendocrinology|March 12, 2018
Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic healthInes Delgado, Lison Huet, Sandra Dexpert, et al.
Brain, Behavior, and Immunity|March 16, 2026
Inflammation-Related alterations in tyrosine metabolism are associated with anhedonia and reduced motivation in Obesity: Influence of Early-Life adversityJuliette Montet, Enrica Montalban, Sandra Dexpert, et al.
Journal of Affective Disorders|December 11, 2019
Evaluation of a virtual agent to train medical students conducting psychiatric interviews for diagnosing major depressive disordersLucile Dupuy, Jean-Arthur Micoulaud-Franchi, Hélène Cassoudesalle, et al.
International Journal of Obesity (2005)|January 10, 2022
Association between the indole pathway of tryptophan metabolism and subclinical depressive symptoms in obesity: a preliminary studyInês Delgado, Sofia Cussotto, Andrea Anesi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2009
Inverse relationship between thalamic and orbitofrontal volumes in obsessive-compulsive disorderJean-Yves Rotge, Bixente Dilharreguy, Bruno Aouizerate, et al.
Pageof 13